Arrowhead Pharmaceuticals Inc. (HDP1)
FSX
Real-time Data
06:00 AM
Day's Range
73.7252 wk Range
17.22Overview - HDP1 - Arrowhead Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
8.82B
P/E (Trailing)
‪45.26‬
P/E (Forward)
‪-153.87‬
PEG Ratio
‪5.70‬
Price / Sales (TTM)
‪15.58‬
Price / Book
‪26.14‬
EV / EBITDA
‪-51.49‬
Profitability
Profit Margin
‪-47.79%‬
Operating Margin
‪-226.02%‬
Return on Assets
‪-8.10%‬
Return on Equity
‪-55.20%‬
Ownership
Shares Outstanding
141.13M
Float
122.45M
Held by Insiders
‪3.66%‬
Held by Institutions
‪85.57%‬
Price stats
Beta
‪1.29‬
50-Day Avg
‪71.74‬
200-Day Avg
‪59.93‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - HDP1 - Arrowhead Pharmaceuticals Inc.
Peers - HDP1 - Arrowhead Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- HDP1FSXArrowhead Pharmaceuticals Inc.10.51BMarket Cap+75.73%52-week change45.26P/E (Trailing)‪-47.79%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.38P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+82.32%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - HDP1 - Arrowhead Pharmaceuticals Inc.
About
Arrowhead Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on developing RNA interference-based medicines to treat diseases driven by genetic abnormalities or excess protein production. The company uses proprietary RNA chemistries and its TRiM platform to selectively silence disease-causing…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
